← Leaderboards
Tyson Heilherker
Boston Children'S Hospital
$4,300,145
Attributed
$4,300,145
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$4,300,145 · 1
By mechanism
N01$4,300,145 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Hanno Steen$18,284,696
- Ofer Levy$33,284,977
- Stephen C Harrison$48,000,876
- Paul Glyndwr Thomas$37,622,980
- Michael R. Farzan$72,884,755
Others in their field
Other Rising Stars on “Adjuvant”
- Warwick Britton · University Of Sydney$10,964,476
- Philip Felgner · University Of California-Irvine$10,234,165
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd$6,937,118
Research focus
AdjuvantAgonistAnalogAdjuvanticityAntigensAustriaBostonCellsChemistryAnimal ModelCytokineEfficacy StudyFamily SuidaeFerretsFormulationGood Laboratory PracticeGood Manufacturing ProcessHemagglutininHigh Throughput ScreeningImmuneImmune ActivationContractorImmune SignalingImmunogenicity
Grant awards (3)
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES$1,000,000
N01 · FY2025 · AI · contact PI
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES$1,481,691
N01 · FY2024 · AI · contact PI
VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES$1,818,454
N01 · FY2023 · AI · contact PI